Brought to you by 
Inotrem closes €18mm Series A round to support sepsis candidate
28 Mar 2014
Executive Summary
In the largest European Series A financing so far this year, French biotech Inotrem SA closed an €18mm ($25mm) first round led by Edmond de Rothschild Investment Partners and Sofinnova Partners, which each add a board member and were joined by Biomed Invest and Inserm Transfert Initiative.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inotrem closes €18mm Series A round to support sepsis candidate
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice